Adaptin Bio (APTN) Current Assets (2022 - 2026)
Adaptin Bio (APTN) posted Current Assets of $706117.0 for Q1 2026, up 14.04% sequentially from $619159.0 in Q4 2025, and down 75.26% YoY from $2.9 million in Q1 2025.
Adaptin Bio (APTN) Current Assets (2022 - 2026) Analysis & Trends
Adaptin Bio has reported Current Assets for 5 years, with the latest figure at $706117.0 in Q1 2026.
- Quarterly Current Assets fell 75.26% year-over-year to $706117.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $706117.0 (down 75.26% YoY) and the FY2025 annual result came in at $619159.0, up 1259.62% from the prior year.
- Current Assets improved to $706117.0 in Q1 2026 per APTN's latest filing, from $619159.0 in the prior quarter.
- Over five years, Current Assets peaked at $2.9 million in Q1 2025 and troughed at $322.0 in Q2 2024.
- A 5-year average of $572434.3 and a median of $23019.5 in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets jumped 750953.68% in 2025, then slumped 75.26% in 2026.
- Over 5 years, Current Assets stood at $500.0 in 2022, then dropped by 24.0% to $380.0 in 2023, then soared by 11883.95% to $45539.0 in 2024, then soared by 1259.62% to $619159.0 in 2025, then increased by 14.04% to $706117.0 in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $706117.0, $619159.0, and $979474.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 981,452.00 |
| Mar 31, 2026 | 706,117.00 |
| Dec 31, 2025 | 619,159.00 |
| Sep 30, 2025 | 979,474.00 |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 45,539.00 |
| Sep 30, 2024 | 322.00 |
| Jun 30, 2024 | 322.00 |
| Mar 31, 2024 | 380.00 |
| Dec 31, 2023 | 380.00 |
| Sep 30, 2023 | 380.00 |
| Dec 31, 2022 | 500.00 |